modelTripelennamine_Wasfi2000_reference

Extends from Pharmacolibrary.Pharmacokinetic.Models.PK_1C.

Information

name:tripelennamine
ATC code:R06AC04
model:one compartment, IV dosing (PK_1C)
source:Wasfi IA et al. 2000
population:horses and camels
measured compound:tripelennamine
review:curated candidate
record page:pharmacolibrary-docs

Parameters as reported in the paper

parametervalueunitmeaning
terminal elimination half-lives (camels)2.39ht1/2z
total body clearances (camels)0.97L/h/kgCL
total body clearances (horses)0.84L/h/kgCLb
volumes of distribution at steady state (camels)2.87L/kgVss
volumes of the central compartment of the two compartment pharmacokinetic model (camels)1.75L/kgV

About tripelennamine

Tripelennamine is an antihistamine used to treat allergic conditions such as urticaria. It is an approved drug, used both systemically for allergies and topically on the skin to relieve itching, and is also approved for veterinary use.

Summary written by glm-5.3-flash from Wikidata Q415203 and the WHO ATC classification; not checked by a person.

Identity, molar mass and metabolites: Tripelennamine.

References

  1. Wasfi IA et al. (2000). Comparative disposition of tripelennamine in horses and camels after intravenous administration. Journal of veterinary pharmacology and therapeutics 23(3):145–152. DOI:10.1046/j.1365-2885.2000.00261.x PUBMED:11110101

Parameters

TypeNameDefaultDescription
RealCl_ref1.886111111111111e-05Cl [m3/s]
RealVd_ref0.1225Vd [m3]
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.0009Volume of distribution per kg (default 0.9 L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)1bioavailability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)2.7777777777777776e-7clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1e-4administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Info › Therapeutic range (metadata, not used in equations)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008maximal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Info › Substance metadata
Modelica.Units.SI.MolarMassMM (from PK_1C)0molar mass [kg/mol]; 0 = not supplied (molar concentrations are then 0)
Info › Substance metadata (not used in equations)
Pharmacolibrary.Types.DoseLD50 (from PK_1C)0median lethal dose [mg/kg]; 0 = unknown

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)central-compartment elimination half-life = ln(2)*Vd/Cl (1-compartment approximation; NOT the terminal half-life of 2-/3-compartment models)

Revisions

  • 11/2026 generated by pharmacolibrary-dev export.pharmacolibrary_models from Wasfi_2000: parameters extracted from the paper by the pharmacolibrary-dev pipeline, model built by its engineer, reviewed: curated candidate